# Commission Regulation (EC) No 761/2009 of 23 July 2009 amending, for the purpose of its adaptation to technical progress, Regulation (EC) No 440/2008 laying down test methods pursuant to Regulation (EC) No 1907/2006 of the European Parliament and of the Council on the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH) (Text with EEA relevance), Division 1.6.1.2.5: Quality controls (QC) of the model

Extent: E+W+S+N.I.

Each batch of the epidermal model used should meet defined production release criteria, among which those for viability (paragraph 1.6.1.2.1) and for barrier function (paragraph 1.6.1.2.2) are the most relevant. An acceptability range (upper and lower limit) for the IC50 or the ET50 should be established by the skin model supplier (or investigator when using an in-house model). The barrier properties of the tissues should be verified by the laboratory after receipt of the tissues. Only results produced with qualified tissues can be accepted for reliable prediction of irritation effects. As an example, the acceptability ranges for the validated reference methods are given below.
Table 2
Examples of QC batch release criteria
Lower acceptance limit
Mean of acceptance range
Upper acceptance limit
Validated reference method 1 (18 hours treatment with SDS)
IC50 = 1,0 mg/ml
IC50 = 2,32 mg/ml
IC50 = 3,0 mg/ml
Validated reference method 2 (1 % Triton X-100)
ET50 = 4,8 hr
ET50 = 6,7 hr
ET50 = 8,7 hr

---
Source: https://www.legislation.gov.uk/eur/2009/761/annex/III/division/1/division/1.6/division/1.6.1/division/1.6.1.2/division/1.6.1.2.5 (the official version)
Page: https://openlegislation.uk/eu-regulation-2009-761/annex-III/division-1/division-1.6/division-1.6.1/division-1.6.1.2/division-1.6.1.2.5
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.

